Dr Patrick ‘Rocky’ Sullivan is a board-certified emergency physician, and is the founder and medical director of Initia Nova in Cherry Hill, NJ. Dr Sullivan completed his residency in 2007, and spent the next 12 years working in a specialized ER, frequently treating acute and chronic psychiatric and substance abuse emergencies. In 2016 he founded his outpatient treatment facility at Initia Nova to offer advanced treatments for these common conditions, as it was clear that the status quo was just not working. After seeing the amazing impact of ketamine infusion therapy on depression, Dr Sullivan continued to expand Initia Nova, offering ketamine assisted psychotherapy for PTSD in 2017, along with groundbreaking treatment programs for alcohol use disorder. In 2018 he began providing TMS, and has developed a personalized accelerated theta burst protocol which provides an excellent alternative to ketamine therapy, or sometimes in conjunction. In 2019 he was trained in the utilization of NAD infusions, and expanded on his addiction treatments with a combination of these advanced techniques plus psychotherapy for a truly comprehensive approach.
In 2019 Dr Sullivan was recruited to work in a specialized Neurologic Emergency Department led by Global Neurosciences Institute. In the Neuro ER he specializes in diagnosing and treating ischemic and hemorrhagic stroke, as well as acute and chronic headaches. Bridging the gap between the physical and psychological aspects of brain science to heal the whole person is the driving focus of Dr. Sullivan’s work. He understands the complex interplay between physical illness and pain, and the neurobiolgy of mood disorders and addiction. Initia Nova also offers a comprehensive headache treatment program, combination a number of advanced treatments and specializing in migraine and post traumatic headache, and the frequent comorbidities that accompany them.
Dr Sullivan is honored to be on the Board of Directors for The American Society of Ketamine Physicians, Psychotherapists and Practitioners, where his goal is to contribute to setting science based and high standards for ketamine therapy.